From: Prevention of suicidal behavior with lithium treatment in patients with recurrent mood disorders
Conditions | Studies (n) | Risk Ratio (RR) [95% CI] | p-value |
---|---|---|---|
All studies | 35 | 3.77 [2.72–5.24] |  < 0.0001 |
Outcomes | |||
 Suicides | 15 | 4.03 [2.37–6.85] |  < 0.0001 |
 Attempts | 8 | 3.73 [1.50–9.33] |  < 0.005 |
 Both | 12 | 3.66 [2.28–5.87] |  < 0.0001 |
Diagnoses | |||
 Bipolar | 14 | 3.84 [2.34–6.30] |  < 0.0001 |
 Major affective | 21 | 3.72 [2.40–5.77] |  < 0.0001 |
 Major depression | 8 | 4.69 [1.66–13.3] |  < 0.0001 |
Trial types | |||
 Open | 29 | 3.95 [2.79–5.58] |  < 0.0001 |
 Randomized, placebo-controlled | 6 | 1.91 [0.89–4.08] | 0.096 |
Comparator type | |||
 vs. placebo or no lithium | 27 | 4.22 [2.91–6.10] |  < 0.0001 |
 vs. anticonvulsants | 8 | 2.42 [1.15–5.10] | 0.02 |